Working… Menu

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02459652
Recruitment Status : Unknown
Verified June 2016 by Japan Adjuvant Study Group of Pancreatic Cancer.
Recruitment status was:  Active, not recruiting
First Posted : June 2, 2015
Last Update Posted : June 29, 2016
Japan Agency for Medical Research and Development
Pharma Valley Center
Information provided by (Responsible Party):
Japan Adjuvant Study Group of Pancreatic Cancer

No Study Results Posted on for this Study
Recruitment Status : Unknown
Actual Primary Completion Date : April 2016
Estimated Study Completion Date : September 2018